Why did Bitcoin perform strongly this November?
How will OPEC+ output hike affect oil prices?
What caused recent delays in SNAP benefit payments?
Why is the U.S. government shutdown impacting air travel?
How is AI driving stock market rallies?
Why are fast-food chicken chains struggling or closing?
What explains Berkshire Hathaway’s rising cash reserves?
Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026
benzinga.com/markets/earnings/25/10/48569116/gileads-hiv-drugs-power-earnings-beat-company-eyes-multiple-launches-by-2026
Gilead Sciences Inc (NASDAQ:GILD) on Thursday reported adjusted earnings of $2.47 per share, beating the consensus of $2.13.
GILD is in positive territory. Get the complete picture here
The U.S. drug maker reported revenues of $7.77 billion, beating the consensus of $7.45…
This story appeared on benzinga.com, 2025-10-31 17:41:12.